Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
Rhea-AI Summary
Indivior (Nasdaq: INDV) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, at 7:00 a.m. U.S. EDT. At 8:00 a.m. U.S. EDT, CEO Joe Ciaffoni and the leadership team will host a live webcast presentation, accessible via the Investors section of www.indivior.com, with telephonic access by advance online registration and a replay available on the company’s website.
Positive
- None.
Negative
- None.
News Market Reaction – INDV
On the day this news was published, INDV gained 0.15%, reflecting a mild positive market reaction. This price movement added approximately $7M to the company's valuation, bringing the market cap to $4.78B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 09 | Q1 earnings date | Neutral | +1.2% | Prior-quarter results reporting date and webcast scheduled for April 30, 2026. |
| Jan 28 | Q4 earnings date | Neutral | +0.6% | Fourth-quarter and full-year results reporting date and webcast scheduled for February 26, 2026. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Both prior earnings-date announcements were followed by positive 24-hour price reactions of 1.16% and 0.55%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT.
Access to the Live Webcast Presentation:
The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the event begins.
Live webcast link: https://edge.media-server.com/mmc/p/yoi9z435
Participants may access the presentation telephonically by registering with the following link:
https://register-conf.media-server.com/register/BI13430f5332af466c963ac5c255f202e0
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
A replay of the presentation will be available at www.indivior.com.
About Indivior
As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine, developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together – with science, people living with OUD, public health champions, and communities – we are powering recovery and renewing hope. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.
For Further Information
Investors:
Jason Thompson
Indivior
Tel: 804-402-7123
E-mail: jason.thompson@indivior.com
Media:
Cassie France-Kelly
Indivior
Tel: 804-594-0836
E-Mail: Indiviormediacontacts@indivior.com
